Hi Mate, Matt here.
If you’ve been following the world of biohacking and metabolic health, you’ve likely seen the massive waves being made by triple agonists like Ret and Tirz. But while everyone is talking about body composition and metabolic pathways, there’s another revolution happening in the research space: one that focuses on the most complex organ of all: the brain.
Today, we’re diving deep into PT-141, also known as Bremelanotide.
This isn’t your standard “blue pill” fix. We aren’t talking about simple blood flow or vascular plumbing. PT-141 is a sophisticated melanocortin agonist that targets the neurological roots of desire. It represents a paradigm shift in how we approach libido research, moving the focus from the periphery of the body straight to the command center of the central nervous system.
